Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval
2 months ago
News Briefing
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
2 months ago
R&D
China
AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron
2 months ago
Deals
China
Johnson & Johnson earmarks $55B to boost US capacity
2 months ago
Pharma
Manufacturing
BridgeBio, Editas finance chiefs depart; Former FDA No. 2 joins Recursion's board
2 months ago
Peer Review
Exclusive: Roivant-backed VantAI debuts AI model Neo-1, taking ‘the big next step’ after AlphaFold 3
2 months ago
AI
Updated: FDA approves Alnylam’s Amvuttra in ATTR-CM, kicking off competition with Pfizer, BridgeBio
2 months ago
Pharma
FDA+
CDC vaccine meeting, delayed earlier this year, is rescheduled
2 months ago
R&D
Pharma
Akero exec calls FDA's accelerated approval guidance for MASH drugs 'bizarre'
2 months ago
R&D
Pharma
Two-thirds of recent rare disease drugs relied on just one trial, plus confirmatory evidence, FDA team finds
2 months ago
FDA+
Novo Nordisk says new early R&D structure will ‘future-proof’ its business
2 months ago
Pharma
Calley Means joins White House as a special government employee, will assist with MAHA policies
2 months ago
People
SV Health Investors nabs $250M to fund dementia-focused biotechs
2 months ago
Financing
Startups
Google is building AI healthcare helpers
2 months ago
Health Tech
Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO
2 months ago
Financing
Startups
Merck to lay off 163 workers in Pennsylvania; Delpharm gets $60M from Canadian government
2 months ago
Manufacturing
Elevation Oncology stops work on ADC, lays off workers; AstraZeneca’s CEPI funding
2 months ago
News Briefing
Like its rivals, Optum Rx is changing its payment models
2 months ago
Health Tech
Illumina was built on DNA. Its future could be biology’s next big wave
2 months ago
In Focus
Diagnostics
Updated: Monte Rosa reports first data for molecular glue program licensed to Novartis
2 months ago
R&D
Paratek boosts commercial portfolio in move to buy Optinose and its nasal spray
2 months ago
Deals
Pharma
Sanofi to pay $600M upfront for Dren Bio’s bispecific B cell depleter
2 months ago
Deals
A California health tech company is letting AI run medical visits, from intake to diagnosis
2 months ago
AI
In Focus
Novartis touts Zolgensma data in older kids as it readies regulatory filings
2 months ago
Pharma
First page
Previous page
26
27
28
29
30
31
32
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit